1. Home
  2. WWR vs DRIO Comparison

WWR vs DRIO Comparison

Compare WWR & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WWR

Westwater Resources Inc.

BUY

Current Price

$0.41

Market Cap

68.8M

ML Signal

BUY

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$3.86

Market Cap

56.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWR
DRIO
Founded
1977
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Mining
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
56.8M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
WWR
DRIO
Price
$0.41
$3.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$2.17
★ $13.60
AVG Volume (30 Days)
★ 693.8K
15.4K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1559.02
EPS
N/A
★ 1.75
Revenue
N/A
★ $7,394,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$38.77
P/E Ratio
★ N/A
$2.61
Revenue Growth
N/A
★ 43.02
52 Week Low
$0.38
$4.56
52 Week High
$1.74
$16.44

Technical Indicators

Market Signals
Indicator
WWR
DRIO
Relative Strength Index (RSI) 24.86 28.09
Support Level $0.38 N/A
Resistance Level $0.45 $8.10
Average True Range (ATR) 0.03 0.57
MACD -0.01 -0.13
Stochastic Oscillator 1.47 0.00

Price Performance

Historical Comparison
WWR
DRIO

About WWR Westwater Resources Inc.

Westwater Resources Inc is an energy technology company focused on developing battery-grade natural graphite materials through a vertically integrated, mine-to-market strategy anchored by its two primary projects in Coosa County, Alabama: the Kellyton Graphite Plant and the Coosa Graphite Deposit. Westwater also holds mineral rights to explore and mine the Coosa Graphite Deposit, which Westwater anticipates will eventually provide natural graphite flake concentrate as feedstock to the Kellyton Graphite Plant.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: